Global Hydrogel Wound Filler Market Overview
Hydrogel Wound Filler Market Size was valued at USD 0.9 Billion in 2023. The hydrogel wound filler market industry is projected to grow from USD 1.0 Billion in 2024 to USD 1.41 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.00% during the forecast period (2024 - 2032). The hydrogel wound filler market is influenced by market drivers like the increase in surgical operations, the frequency of both acute and chronic wounds, and the aging patient base.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Hydrogel Wound Filler Market Trends
-
Growing incidence of infection is driving the market growth
Throughout the projection period, the general population's growing incidence of chronic wounds, such as pressure ulcers and diabetic foot ulcers, is anticipated to drive treatment volume and propel the uptake of wound care products. Additionally, it is projected that during the forecast period, the prevalence of acute wounds, such as burns and surgical wounds, among the world's population would rise, driving up demand for hydrogel wound filler. For instance, surgical wounds are a major concern in healthcare overall, according to the Wound Healing Society (WHS). Despite all attempts, surgical site infections (SSI) account for 75.0% of cases worldwide when death occurs. As a result, the growing incidence of infections has placed a significant financial strain on the healthcare sector, which is projected to encourage the introduction of cutting-edge technologies and accelerate the expansion of the Hydrogel Wound Filler Market.
The advancements in healthcare, the increasing occurrence of undesired health issues, and the increase in burn, diabetes, and ulcer cases have created an attractive market for healthcare companies. Besides, the ones with a developing economy, such as the US and Canada, are the better markets to participate in for the major players of the hydrogel wound filler industry owing to their large populations, rising knowledge about hydrogel dressings, and increasing demand for treating the state-of-the-art ailments. In addition, the demand for higher-end healthcare services is rising and alongside this trend, governments in emerging nations are making substantial investments to improve the healthcare system and the medical tourism business is growing in these countries, which are all contributing to the fast growth of the healthcare industry in emerging economies. On the other hand, this hydrogel wound filler exhibits a range of merits, like refilling the wound bed with fluid to reduce the pain for patients since it cools the area and accelerates autolytic debridement. Statistically, the current wound care industry could be regarded as large and would probably develop at a high pace based on the CDC (Centers for Disease Control and Prevention) estimate. Consequently, the forecast period is expected to witness the other governed areas having a positive impact on the hydrogel wound filler market CAGR growth.
The need for hydrogel wound filler rises as the prevalence of diabetes rises and the intricacy of diabetic foot ulcers increases. About 422 million people around the globe have diabetes, most of whom live in low- and middle-income countries, according to the updated data from 2024. An estimated 1.5 million deaths each year are directly related to the condition. The incidence of diabetes and the number of cases have both steadily increased during the previous several decades. Foot ulcers are among the most common diabetic foot complications, according to Clinical Diabetes and Endocrinology in 2023. Of the estimated 2.5% of diabetics, 14–24% of patients would require the amputation of their diabetic foot lesions. Thus, driving the hydrogel wound filler market revenue.
Hydrogel Wound Filler Market Segment Insights
Hydrogel Wound Filler Product Insights
The Hydrogel Wound Filler Market segmentation, based on product, includes Amorphous Hydrogel Dressings, Impregnated Gauze, Hydrogel Sheets, and Other Products. In 2023, the amorphous hydrogel dressings segment dominated the market. This can be explained by the overuse of amorphous hydrogel dressings, which have an advantage over other dressings in encouraging effective wound healing and treating ulcers and wounds rather than impregnated gauze and hydrogel sheets.
Hydrogel Wound Filler Wound Type Insights
The Hydrogel Wound Filler Market segmentation, based on wound type, includes Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Burns, and Other Wounds. The diabetic foot ulcers category generated the most income in 2023. The main factor driving the increase in sales of hydrogel wound fillers for the treatment of diabetic foot ulcers is their dominant market position. According to studies, there are an estimated 13.5 million diabetic foot ulcer sufferers in the world. The fact that these ulcers heal more slowly and require more frequent treatments is another factor driving up demand for the products.
Figure 1: Hydrogel Wound Filler Market, by Wound Type, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Hydrogel Wound Filler Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American hydrogel wound filler market area will dominate this market because the cost of providing healthcare in North America is rising, and there is a need for efficient hydrogel dressings. Additionally, increasing government measures to lessen the cost burden are anticipated to support hydrogel wound filler market expansion throughout the projection period.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: Hydrogel Wound Filler Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe hydrogel wound filler market accounts for the second-largest market share, fueled by the senior population's expansion, a huge population base, a rise in disposable income, increased demand for innovative technology, and increased knowledge of treatments for chronic wound infections. Further, the German hydrogel wound filler market held the largest market share, and the UK hydrogel wound filler market was the fastest growing market in the European region.
The Asia-Pacific Hydrogel Wound Filler Market is expected to grow at the fastest CAGR from 2024 to 2032 due to a growth in the prevalence of chronic illnesses, a rise in disposable income, a rise in patient knowledge of hydrogel dressings, and a sharp increase in the market for hydrogel wound filler. Moreover, China’s hydrogel wound filler market held the largest market share, and the Indian hydrogel wound filler market was the fastest growing market in the Asia-Pacific region.
Hydrogel Wound Filler Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the hydrogel wound filler market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, hydrogel wound filler industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global hydrogel wound filler industry to benefit clients and increase the market sector. In recent years, the hydrogel wound filler industry has offered some of the most significant advantages to medicine. Major players in the hydrogel wound filler market are attempting to increase market demand by investing in research and development operations, including 3M (US), Molnlycke Health Care Ab (Sweden), Convatec Group Plc (UK), Advanced Medical Solutions Group plc (UK), Paul Hartmann AG (Germany), DeRoyal Industries (US), Coloplast A/S (Denmark), Cardinal Health, Inc. (US), and Derma Sciences (US).
Medical technology and products are supplied by ConvaTec Group Plc (ConvaTec). Advanced wound care, ostomy care, infusion devices, and continence and critical care are the company's areas of expertise. Major items include skin care products, wound dressings, urological catheters, disposable infusion sets, and equipment and accessories for individuals with illnesses such as multiple sclerosis, urinary continence, diabetes, spina bifida, ostomy, ulcers, and spinal cord injuries. Through a network of distributors, ConvaTec provides products directly and indirectly to insulin pump manufacturers, hospitals, homecare agencies, pharmacies, and retail distributors in the homecare industry.
Medical, surgical, and hygiene supplies are supplied by Paul Hartmann AG (Hartmann). The company offers a range of items such as medical skin care, diagnostics, wound care, incontinence management, therapeutic bandages, first aid, operating theatre supplies, and feminine hygiene. Through a variety of distribution channels, including group-owned distribution centers and independent distributors, Hartmann sells its goods and services to healthcare facilities, physician offices, assisted living facilities, and homecare services.
Key companies in the hydrogel wound filler market include
- 3M (US)
- Molnlycke Health Care Ab (Sweden)
- Convatec Group Plc (UK)
- Advanced Medical Solutions Group plc (UK)
- Paul Hartmann AG (Germany)
- DeRoyal Industries (US)
- Coloplast A/S (Denmark)
- Cardinal Health, Inc. (US)
- Derma Sciences (US)
Hydrogel Wound Filler Industry Developments
January 2023: With regard to its coactiv+TM Antimicrobial Hydrogel wound care and DermaKBTM scalp care products, Kane Biotech Inc. stated that it has entered into a distribution agreement with Salud Pharma S.A. ("Salud Pharma").
Hydrogel Wound Filler Market Segmentation
Hydrogel Wound Filler Product Outlook
- Amorphous Hydrogel Dressings
- Impregnated Gauze
- Hydrogel Sheets
- Other Products
Hydrogel Wound Filler Wound Type Outlook
- Surgical & Traumatic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Burns
- Other Wounds
Hydrogel Wound Filler Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
-
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2023 |
USD 0.9 Billion |
Market Size 2024 |
USD 1.0 Billion |
Market Size 2032 |
USD 1.41 Billion |
Compound Annual Growth Rate (CAGR) |
5.00% (2024-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2019-2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Product, Wound Type, and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered |
The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
3M (US), Molnlycke Health Care Ab (Sweden), Convatec Group Plc (UK), Advanced Medical Solutions Group plc (UK), Paul Hartmann AG (Germany), DeRoyal Industries (US), Coloplast A/S (Denmark), Cardinal Health, Inc. (US), and Derma Sciences (US). |
Key Market Opportunities |
ยทย ย ย ย ย ย ย ย Increase in Diabetes, Ulcers, and Obesity Cases |
Key Market Dynamics |
ยทย ย ย ย ย ย ย ย Growing Rates of Both Acute and Chronic Injuries ยทย ย ย ย ย ย ย ย Growing Knowledge of the Benefits and Applications of Hydrogel |
Frequently Asked Questions (FAQ) :
The Hydrogel Wound Filler Market size was valued at USD 0.9 Billion in 2023.
The global market is projected to grow at a CAGR of 5.00% during the forecast period, 2024-2032.
North America had the largest share in the global market
The key players in the market are 3M (US), Molnlycke Health Care Ab (Sweden), Convatec Group Plc (UK), Advanced Medical Solutions Group plc (UK), Paul Hartmann AG (Germany), DeRoyal Industries (US), Coloplast A/S (Denmark), Cardinal Health, Inc. (US), and Derma Sciences (US).
The diabetic foot ulcers category dominated the market in 2023.
The amorphous hydrogel dressings category had the largest share in the global market.